BRS3 and neuroendocrine neoplasm: The availability of characterized BRS3-Cre driver alleles facilitates investigation of BRS3 function in pancreatic islets (Feng et al., 2011), neuroendocrine tumors (Sherman et al., 2014), and certain cancers (Moreno et al., 2018; Ramos-Alvarez et al., 2019).